Though recombinant factor VIIa didn’t improve outcomes overall, treating very early and in those with a spot sign on CT may ...
Ocular Therapeutix, Inc. (NASDAQ: OCUL, "Ocular”), an integrated biopharmaceutical company committed to redefining the retina ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果